Cleared Traditional

K820499 - FITC ANTI-RABIES MONOCLONAL GLOBULIN
(FDA 510(k) Clearance)

Apr 1982
Decision
52d
Days
Class 2
Risk

K820499 is an FDA 510(k) clearance for the FITC ANTI-RABIES MONOCLONAL GLOBULIN. This device is classified as a Antiserum, Fluorescent, Rabies Virus (Class II - Special Controls, product code GOI).

Submitted by Centocor, Inc. (Mchenry, US). The FDA issued a Cleared decision on April 16, 1982, 52 days after receiving the submission on February 23, 1982.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3460.

Submission Details

510(k) Number K820499 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 23, 1982
Decision Date April 16, 1982
Days to Decision 52 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary

Device Classification

Product Code GOI — Antiserum, Fluorescent, Rabies Virus
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3460